WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing report

Search
Enter keywords, a title or a report id number below.
Advanced

• ORDER BY FAX

Order By Fax

• SELECT SITE CURRENCY

Select a currency for use throughout the site



  • Electronic (PDF) Information Icon
  • Site License Information Icon
  • Enterprisewide Information Icon
Live Chat Live Help Software for Website

Dietary Fiber Supplement Manufacturing in the US

IBISWorld, March 2012, Pages: 31

On schedule: Health concerns and rising disposable incomes will strengthen revenue

Dietary Fiber Supplement Manufacturing

Back on track

Because the industry sells what is generally a discretionary good, the recession caused revenue declines in 2008 and 2009, but the industry has recovered well. An aging population and the public's increasing concern over health issues has brought revenue growth back into the positive, and will continue to do so through 2017. However, FDA regulations and the Healthcare Reform Act of 2010 could hamper future industry growth.

This industry develops and produces dietary fiber supplements, which are ingested to remedy deficiencies of carbohydrates that the human body fails to completely digest. Supplements may be marketed to consumers for nutritional purposes, treatment of gastrointestinal disorders or other health benefits.

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.

ABOUT THIS INDUSTRY
Industry Definition
Main Activities
Similar Industries
Additional Resources

INDUSTRY AT A GLANCE

INDUSTRY PERFORMANCE
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle

PRODUCTS & MARKETS
Supply Chain
Products & Services
Demand Determinants
Major Markets
International Trade
Business Locations

COMPETITIVE LANDSCAPE
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Basis of Competition
Barriers to Entry
Industry Globalization

MAJOR COMPANIES

OPERATING CONDITIONS
Capital Intensity
Technology & Systems
Revenue Volatility
Regulation & Policy
Industry Assistance

KEY STATISTICS
Industry Data
Annual Change
Key Ratios

JARGON & GLOSSARY

MAJOR COMPANIES.

The Procter & Gamble Company

Novartis AG

GlaxoSmithKline PLC

Customers who bought this item also bought